Cargando…

Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?

The availability of disease-modifying drugs for the management of autosomal dominant polycystic kidney disease (ADPKD) has accelerated the need to accurately predict renal prognosis and/or treatment response in this condition. Arginine vasopressin (AVP) is a critical determinant of postnatal kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tasneem, Moomal, Mannix, Carly, Wong, Annette, Zhang, Jennifer, Rangan, Gopala
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838414/ https://www.ncbi.nlm.nih.gov/pubmed/29527508 http://dx.doi.org/10.5527/wjn.v7.i2.51

Ejemplares similares

Relative Validity of a Beverage Frequency Questionnaire Used to Assess Fluid Intake in the Autosomal Dominant Polycystic Kidney Disease Population
por: Mannix, Carly, et al.
Publicado: (2018)

Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease
por: Zhang, Jennifer Q. J., et al.
Publicado: (2021)

Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease
por: Sagar, Priyanka S., et al.
Publicado: (2019)

Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease
por: Chandra, Ashley N., et al.
Publicado: (2021)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells
por: Ta, Michelle H. T., et al.
Publicado: (2015)

Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney Disease
por: Saravanabavan, Sayanthooran, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease (ADPKD) is associated with coronary arterial dilatation in end-stage renal failure patients
por: Chiha, Joseph, et al.
Publicado: (2012)

Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease
por: Zhang, Jennifer Q. J., et al.
Publicado: (2021)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study
por: Arjune, Sita, et al.
Publicado: (2023)

Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease
por: Wong, Annette T. Y., et al.
Publicado: (2020)

Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease
por: Amin, Sneha, et al.
Publicado: (2023)

Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease
por: Blijdorp, Charles J, et al.
Publicado: (2020)

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
por: Wong, Annette T Y, et al.
Publicado: (2018)

Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers
por: Sorić Hosman, Iva, et al.
Publicado: (2023)

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease
por: Leierer, Johannes, et al.
Publicado: (2021)

Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease
por: Karner, Larina A., et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease
por: Kimura, Tomoki, et al.
Publicado: (2023)

The modifiers of chronic kidney disease in autosomal dominant polycystic kidney disease and the role of the endothelin-1
por: Einollahi, Behzad, et al.
Publicado: (2016)

Kidney volume and function in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2013)

Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review
por: Natale, Patrizia, et al.
Publicado: (2021)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
por: Radhakrishnan, Yeshwanter, et al.
Publicado: (2022)

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease
por: Tangri, Navdeep, et al.
Publicado: (2017)

Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression
por: Piazzon, Nathalie, et al.
Publicado: (2015)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
por: Kim, Hyunsuk, et al.
Publicado: (2022)

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
por: Ryu, Hyunjin, et al.
Publicado: (2020)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jd8mgbvsd1kr7nfnis7h7m0q2m